Vanguard Global Advisers
TNDM icon

Vanguard Global Advisers’s Tandem Diabetes Care TNDM Stock Holding History

Vanguard Global Advisers’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$406K Sell
26,897
-62
-0.2% -$1.08K ﹤0.01% 2193
2026
Q1 		$517K Buy
+26,959
New +$586K ﹤0.01% 2026

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Vanguard Global Advisers's TNDM Position: Q2 2026 in Review

Vanguard Global Advisers reduced its Tandem Diabetes Care (TNDM) stake by 0.23% in Q2 2026, selling an estimated $1.08K and leaving 26,897 shares worth $406K. The position accounts for ﹤0.01% of the portfolio, ranked #2193.

Vanguard Global Advisers first reported a position in TNDM in Q1 2026 and has held it in 2 quarters since. The position peaked at $517K in Q1 2026. 270 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Vanguard Global Advisers held 26,897 shares of Tandem Diabetes Care worth $406K as of Q2 2026.
  • Vanguard Global Advisers sold 62 Tandem Diabetes Care shares in Q2 2026, an estimated $1.08K.
  • Tandem Diabetes Care made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #2193 holding.
  • Vanguard Global Advisers first reported a position in Tandem Diabetes Care in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Global Advisers's Tandem Diabetes Care position peaked at $517K in Q1 2026.
  • 270 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.